Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy
By K. Harris, P. Spirito, M. Maron, A. Zenovich, Francesco Formisano, John R. Lesser, Shannon M. Mackey-Bojack, Warren J. Manning, J. Udelson, B. Maron. Circulation, 2006
637 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/a75868964e83853d0426558698950fe631861727
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- B. Maron
- M. Maron
- P. Spirito
- Iacopo Olivotto
- J. Udelson
- Francesco Formisano
- H. Rakowski
- John R. Lesser
In Surgery
Citations in the corpus
- Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy (2014, methodology): “The capability to prospectively identify patients who will progress to the end stage is clinically relevant by permitting anticipation of changes in clinical course and management strategies, including tailored drug administration and early consideration for heart transplantation and prophylactic de”
- The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. (2016, background): “The most advanced form of heart failure in HCM is endstage (or “burned out”) HCM, which arises in a small distinct sub-set of patients with non-obstructive disease (prevalence 3%).(76) Progression of heart failure is associated with conversion to systolic dysfunction (LV ejection fraction o 50%) wit”